GlaxoSmithKline (GSK ... in product management for the Near East-East Africa in Boehringer Ingelheim. In 2002 he joined Schering Plough and had various positions including running the company ...
30, 2023, to June 30, 2024, the managers sold out of three positions (GSK PLC, BCE ... first as a financials analyst, and from 2002 through 2017 as director of global research.
The era of mega-mergers Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009 ...
Avid was founded in 2002 as a spinout of biopharmaceutical company Peregrine Pharmaceuticals. “Since our founding, Avid ...
Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Teva Pharmaceutical Industries Ltd. ADR 1.52% $19.75B ...
Context: Incidents involving anthrax (Bacillus anthracis) through the mail in 4 metropolitan areas have raised concerns about the public's response nationally and locally. Objective: To examine ...
As of November 08, 2024, GSK plc had a $73.1 billion market capitalization, putting it in the 96th percentile of companies in the Pharmaceuticals industry. Currently, GSK plc’s price-earnings ratio is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback